Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
Three broad-spectrum cephalosporins (cefotetan, moxalactam, and cefoxitin) proved effective in this randomized, prospective trial for treatment of 303 surgical patients with moderately severe regional peritonitis.
Wilson
S E
SE
Department of Surgery, Harbor-UCLA Medical Center, Torrance.
Boswick
J A
JA
Duma
R J
RJ
Echols
R M
RM
Jemsek
J G
JG
Lerner
R
R
Lewis
R T
RT
Najem
A Z
AZ
Press
R A
RA
Rittenbury
M S
MS
D001424:Bacterial Infections / Q000188:drug therapy*; D015313:Cefotetan; D002440:Cefoxitin / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009070:Moxalactam / Q000627:therapeutic use*; D010538:Peritonitis / Q000188:drug therapy*; D011446:Prospective Studies; D011897:Random Allocation; D013997:Time Factors
D002513:Cephamycins; D015313:Cefotetan; D002440:Cefoxitin; D009070:Moxalactam